← All indications
Cholestasis
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
Subtype terms (3)
More specific conditions that are subtypes of Cholestasis in the MeSH hierarchy.
- Cholestasis, Extrahepatic
1 drug approved
- Cholestasis, Intrahepatic
11 drugs (8 approved, 3 experimental)
- Mirizzi Syndrome
Drugs by status
Approved for this indication (4)
Phase 4 trials (4)
Phase 3 trials (8)
Phase 2 trials (3)
Phase 1 trials (7)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (50)
- Abbott
- Shire
- Fresenius
- Travere
- Albireo
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- University of Manitoba
- Beijing Trendful Kangjian Medical Information Consulting Limited Company
- University of London
- Harvard University
- University of Washington
- Indiana University
- Kapiolani Medical Center For Women & Children
- Kunming Medical University
- Sichuan University
- Thammasat University
- University of Florida
- University of Michigan
- University of South Florida
- University of Toronto
- University of Alberta
- University of Bologna
- Columbia University
- Epsom and St Helier University Hospitals NHS Trust
- Mednax Center for Research, Education and Quality
- Peking University
- University of British Columbia
- +20 more
Organization Involved with Phase 2 Indications (19)
- HighTide Biopharma Pty Ltd
- National Center for Research Resources (NCRR)
- Amarnath, Rathna, M.D.
- University of Pittsburgh
- Arizona State University
- Northwell Health
- University of Nebraska
- University of Oklahoma
- University of South Carolina
- University of California, Davis
- University of California, San Diego
- Conatus Pharmaceuticals
- Karolinska Institute
- Cohen Children's Medical Center of New York
- University of North Carolina, Charlotte
- University of Texas, San Antonio
- Idun Pharmaceuticals
- Government of Egypt
- The University of Texas, Dallas
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (13)
- Advocate Health Care
- Dr. Sami Ulus Children's Hospital
- University of Pennsylvania
- Baylor University
- Carle Foundation Hospital
- Geisinger Clinic
- Georgetown University
- Seoul National University
- Icahn School of Medicine at Mount Sinai
- Advocate Healthcare
- Rush University
- State University of New York, Brooklyn
- West China Hospital